68 related articles for article (PubMed ID: 1320297)
1. Computer simulation and modelling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy.
Düchting W; Ulmer W; Lehrig R; Ginsberg T; Dedeleit E
Strahlenther Onkol; 1992 Jun; 168(6):354-60. PubMed ID: 1320297
[TBL] [Abstract][Full Text] [Related]
2. Computer simulation of fractionated radiotherapy: further results and their relevance to percutaneous irradiation and brachytherapy.
Ginsberg T; Ulmer W; Düchting W
Strahlenther Onkol; 1993 May; 169(5):304-10. PubMed ID: 8503090
[TBL] [Abstract][Full Text] [Related]
3. Modeling of radiogenic responses induced by fractionated irradiation in malignant and normal tissue.
Düchting W; Ginsberg T; Ulmer W
Stem Cells; 1995 May; 13 Suppl 1():301-6. PubMed ID: 7488961
[TBL] [Abstract][Full Text] [Related]
4. Radiogenic responses of normal cells induced by fractionated irradiation--a simulation study. Part II. Late responses.
Düchting W; Ulmer W; Ginsberg T; Kikhounga-N'Got O; Saile C
Strahlenther Onkol; 1995 Sep; 171(9):525-33. PubMed ID: 7570301
[TBL] [Abstract][Full Text] [Related]
5. Computer simulation of clinical irradiation schemes applied to in vitro tumor spheroids.
Düchting W; Lehrig R; Rademacher G; Ulmer W
Strahlenther Onkol; 1989 Dec; 165(12):873-8. PubMed ID: 2603123
[TBL] [Abstract][Full Text] [Related]
6. Radiogenic responses of normal tissue induced by fractionated irradiation--a simulation study. I. Acute effects.
Düchting W; Ulmer W; Ginsberg T; Saile C
Strahlenther Onkol; 1995 Aug; 171(8):460-7. PubMed ID: 7652669
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
8. [Local efficiency of percutaneous radiotherapy in lung cancer. Analysis of 215 repeated bronchoscopies in relation to applied radiation dosage].
Schwegler N; Vrh N; Kern T; Notter M; Frey M; Grossenbacher M; Hausmann M; Pfenninger T; Ragaz A; Schmid R; Siebenschein R; Keller R
Strahlenther Onkol; 1996 Feb; 172(2):81-90. PubMed ID: 8669049
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of super-fractionated irradiation in the radiotherapy of inoperable lung cancer].
Leskov VP; Larin BS; Mardynskiĭ IuS
Med Radiol (Mosk); 1986 Jun; 31(6):7-11. PubMed ID: 3014259
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
11. Reoxygenation of hypoxic cells by tumor shrinkage during irradiation. A computer simulation.
Kocher M; Treuer H
Strahlenther Onkol; 1995 Apr; 171(4):219-30. PubMed ID: 7740410
[TBL] [Abstract][Full Text] [Related]
12. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
van Baardwijk A; Bosmans G; Bentzen SM; Boersma L; Dekker A; Wanders R; Wouters BG; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1103-10. PubMed ID: 18258382
[TBL] [Abstract][Full Text] [Related]
13. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
14. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase.
Chatani M; Matayoshi Y; Masaki N; Inoue T
Strahlenther Onkol; 1994 Mar; 170(3):155-61. PubMed ID: 8160096
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
[TBL] [Abstract][Full Text] [Related]
17. [Prophylactic brain irradiation and radiotherapy of brain metastases of small cell lung cancer].
Mikhina ZP; Motorina LI; Glekov IV
Vopr Onkol; 1985; 31(10):61-70. PubMed ID: 2998092
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
19. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
20. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
